To evaluate a specific role of PGE2-EP4 signaling in pro-tumor myeloid cell activation, we assayed effects of PGE2 with or without E7046 and antagonists specific for EP1–3 in a modified BioMap assay system.29 Here, PTGER1 is linked to neoplasm.